BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 33024120)

  • 21. Effect of berberine on spleen transcriptome and gut microbiota composition in experimental autoimmune uveitis.
    Du Z; Wang Q; Huang X; Yi S; Mei S; Yuan G; Su G; Cao Q; Zhou C; Wang Y; Kijlstra A; Yang P
    Int Immunopharmacol; 2020 Apr; 81():106270. PubMed ID: 32044663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response effect of berberine on bile acid profile and gut microbiota in mice.
    Guo Y; Zhang Y; Huang W; Selwyn FP; Klaassen CD
    BMC Complement Altern Med; 2016 Oct; 16(1):394. PubMed ID: 27756364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
    McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
    BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effects of
    Shin NR; Gu N; Choi HS; Kim H
    Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.
    Liu A; Ma T; Xu N; Jin H; Zhao F; Kwok LY; Zhang H; Zhang S; Sun Z
    Microbiol Spectr; 2021 Oct; 9(2):e0085921. PubMed ID: 34612663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.
    Firouzi S; Majid HA; Ismail A; Kamaruddin NA; Barakatun-Nisak MY
    Eur J Nutr; 2017 Jun; 56(4):1535-1550. PubMed ID: 26988693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
    Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
    J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice.
    Shi Y; Hu J; Geng J; Hu T; Wang B; Yan W; Jiang Y; Li J; Liu S
    Biomed Pharmacother; 2018 Nov; 107():1556-1563. PubMed ID: 30257374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus.
    He Q; Dong H; Guo Y; Gong M; Xia Q; Lu F; Wang D
    Front Endocrinol (Lausanne); 2022; 13():1074348. PubMed ID: 36465656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.
    Sasaki M; Ogasawara N; Funaki Y; Mizuno M; Iida A; Goto C; Koikeda S; Kasugai K; Joh T
    BMC Gastroenterol; 2013 May; 13():81. PubMed ID: 23657005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
    Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
    Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
    Wang Y; Tong Q; Ma SR; Zhao ZX; Pan LB; Cong L; Han P; Peng R; Yu H; Lin Y; Gao TL; Shou JW; Li XY; Zhang XF; Zhang ZW; Fu J; Wen BY; Yu JB; Cao X; Jiang JD
    Signal Transduct Target Ther; 2021 Feb; 6(1):77. PubMed ID: 33623004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice.
    Li M; Zhou W; Dang Y; Li C; Ji G; Zhang L
    Biomed Pharmacother; 2020 Dec; 132():110953. PubMed ID: 33254441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Berberine on the Gut Microbiota in Apc
    Wang H; Guan L; Li J; Lai M; Wen X
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580
    [No Abstract]   [Full Text] [Related]  

  • 37. The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
    Wang H; Zhang H; Gao Z; Zhang Q; Gu C
    Front Cell Infect Microbiol; 2022; 12():854885. PubMed ID: 36093200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
    Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
    NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
    Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
    Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.